These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33778872)

  • 1. Impact of diabetes on coronary severity and cardiovascular outcomes in patients with heterozygous familial hypercholesterolaemia.
    Liu MM; Peng J; Guo YL; Wu NQ; Zhu CG; Gao Y; Dong Q; Li JJ
    Eur J Prev Cardiol; 2022 Jan; 28(16):1807-1816. PubMed ID: 33778872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension and clinical outcomes in patients with familial hypercholesterolemia.
    Liu MM; Peng J; Xu RX; Guo YL; Zhu CG; Wu NQ; Li JJ
    J Hypertens; 2022 Sep; 40(9):1713-1721. PubMed ID: 35943100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and genetic characteristics of familial hypercholesterolemia patients with type 2 diabetes.
    Sun D; Cao YX; You XD; Zhou BY; Li S; Guo YL; Zhang Y; Wu NQ; Zhu CG; Gao Y; Dong QT; Liu G; Dong Q; Li JJ
    J Endocrinol Invest; 2019 May; 42(5):591-598. PubMed ID: 30276670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial 8-hydroxy-2'-deoxyguanosine and coronary artery disease in patients with type 2 diabetes mellitus.
    Wang XB; Cui NH; Liu X; Liu X
    Cardiovasc Diabetol; 2020 Feb; 19(1):22. PubMed ID: 32075646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and genetic differences between heterozygous familial hypercholesterolemia patients with and without type 2 diabetes.
    Climent E; Pérez-Calahorra S; Benaiges D; Pintó X; Suárez-Tembra M; Plana N; Sánchez-Hernández RM; Valdivielso P; Ascaso JF; Pedro-Botet J
    Rev Esp Cardiol (Engl Ed); 2020 Sep; 73(9):718-724. PubMed ID: 31672559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SYNTAX score-0 patients: risk stratification in nonobstructive coronary artery disease.
    Sinning C; Zengin E; Waldeyer C; Seiffert M; Schnabel RB; Lubos E; Zeller T; Bickel C; Blankenberg S; Clemmensen PM; Westermann D
    Clin Res Cardiol; 2016 Nov; 105(11):901-911. PubMed ID: 27364941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in phenotype, genotype and cardiovascular events between patients with probable and definite heterozygous familial hypercholesterolemia.
    Cao YX; Zhou BY; Sun D; Li S; Guo YL; Zhu CG; Wu NQ; Gao Y; Xu RX; Liu G; Dong Q; Li JJ
    Per Med; 2019 Nov; 16(6):467-478. PubMed ID: 31691639
    [No Abstract]   [Full Text] [Related]  

  • 8. The additive effect of essential hypertension on coronary artery plaques in type 2 diabetes mellitus patients: a coronary computed tomography angiography study.
    Jiang Y; Li Y; Shi K; Wang J; Qian WL; Yan WF; Pang T; Yang ZG
    Cardiovasc Diabetol; 2022 Jan; 21(1):1. PubMed ID: 34983514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated lipoprotein (a) levels are associated with the presence and severity of coronary artery disease in patients with type 2 diabetes mellitus.
    Zhang HW; Zhao X; Guo YL; Gao Y; Zhu CG; Wu NQ; Li JJ
    Nutr Metab Cardiovasc Dis; 2018 Oct; 28(10):980-986. PubMed ID: 30030022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary severity score and C-reactive protein predict major adverse cardiovascular events in patients with stable coronary artery disease (from the Taichung CAD study).
    Pan HC; Sheu WH; Lee WJ; Lee WL; Liao YC; Wang KY; Lee IT; Wang JS; Liang KW
    Clin Chim Acta; 2015 May; 445():93-100. PubMed ID: 25818243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duration of type 2 diabetes mellitus and systolic blood pressure as determinants of severity of coronary stenosis and adverse events in an asymptomatic diabetic population: PROCEED study.
    Venuraju SM; Lahiri A; Jeevarethinam A; Cohen M; Darko D; Nair D; Rosenthal M; Rakhit RD
    Cardiovasc Diabetol; 2019 Apr; 18(1):51. PubMed ID: 31014330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk stratification of coronary artery disease in asymptomatic diabetic subjects using multidetector computed tomography.
    Shimabukuro M; Saito T; Higa T; Nakamura K; Masuzaki H; Sata M;
    Circ J; 2015; 79(11):2422-9. PubMed ID: 26399764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between the Finnish Diabetes risk Score and the severity of coronary artery disease.
    Djurić P; Mladenović Z; Grdinić A; Tavčiovski D; Spasić M; Davičević-Elez Z
    Vojnosanit Pregl; 2014 May; 71(5):474-80. PubMed ID: 26137713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of heterozygous familial hypercholesterolaemia and its impact on long-term prognosis in patients with very early ST-segment elevation myocardial infarction in the era of statins.
    Rallidis LS; Triantafyllis AS; Tsirebolos G; Katsaras D; Rallidi M; Moutsatsou P; Lekakis J
    Atherosclerosis; 2016 Jun; 249():17-21. PubMed ID: 27062405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relations of physical signs to genotype, lipid and inflammatory markers, coronary stenosis or calcification, and outcomes in patients with heterozygous familial hypercholesterolemia.
    Liu MM; Peng J; Guo YL; Zhu CG; Wu NQ; Xu RX; Dong Q; Li JJ
    J Transl Med; 2021 Dec; 19(1):498. PubMed ID: 34876165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High cardiovascular risk of patients with type 2 diabetes is only partially attributed to angiographic burden of atherosclerosis.
    Battermann S; Milzi A; Dettori R; Burgmaier K; Marx N; Burgmaier M; Reith S
    Diab Vasc Dis Res; 2020; 17(9):1479164120953612. PubMed ID: 32962403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated blood urea nitrogen-to-creatinine ratio increased the risk of Coronary Artery Disease in patients living with type 2 diabetes mellitus.
    Liu F; Ma G; Tong C; Zhang S; Yang X; Xu C; Yang W; Xia G; Li M
    BMC Endocr Disord; 2022 Feb; 22(1):50. PubMed ID: 35227230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiographic score assessment improves cardiovascular risk prediction: the clinical value of SYNTAX and Gensini application.
    Sinning C; Lillpopp L; Appelbaum S; Ojeda F; Zeller T; Schnabel R; Lubos E; Jagodzinski A; Keller T; Munzel T; Bickel C; Blankenberg S
    Clin Res Cardiol; 2013 Jul; 102(7):495-503. PubMed ID: 23519584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence, Characteristics, and Volumes of Coronary Plaque Determined by Computed Tomography Angiography in Young Type 2 Diabetes Mellitus.
    Nezarat N; Budoff MJ; Luo Y; Darabian S; Nakanishi R; Li D; Sheidaee N; Kim M; Alani A; Matsumoto S; Rahmani S; Kanisawa M; Ceponiene I; Osawa K; Qi H; Hamal S; Kitslaar P; Broersen A; Flores F; Ipp E; Khazai B
    Am J Cardiol; 2017 May; 119(10):1566-1571. PubMed ID: 28343599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between fibrinogen levels and severity of coronary artery disease and long-term prognosis following percutaneous coronary intervention in patients with type 2 diabetes mellitus.
    Su H; Cao Y; Chen Q; Ye T; Cui C; Chen X; Yang S; Qi L; Long Y; Xiong S; Cai L
    Front Endocrinol (Lausanne); 2023; 14():1287855. PubMed ID: 38093962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.